News AI could revolutionise pharma compound synthesis Researchers at the University of Cambridge in the UK and Pfizer have developed an artificial intelligence (AI)-powered platform that could refine and accelerate the way ph
Events Partner Content World Congress on Pharmacology and Chemistry of Natural Comp... Natural Compounds 2018
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face